Skip to main content
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 21.76
Day High 22.85
Open:22.05
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Healthcare-associated Infectious Disease Diagnostics Market Research Report by Product & Service, by Disease Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
- PR Newswire - PRF - Thu Oct 29, 10:10AM CDT
PR Newswire - PRF - CMTX
Thu Oct 29, 10:10AM CDT
, /PRNewswire/ --
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020
- PR Newswire - PRF - Thu Oct 22, 6:00AM CDT
PR Newswire - PRF - CMTX
Thu Oct 22, 6:00AM CDT
, /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended on . A press release announcing the results is scheduled for release after the close of trading on that date.
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020
- PR Newswire - Thu Oct 22, 6:00AM CDT
PR Newswire - PRNW
Thu Oct 22, 6:00AM CDT
AUSTIN, Texas , Oct. 22, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020 . A press release announcing the results is scheduled for release after the close of trading on that date.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 20.61 +9.70% increase
on 10/21/20
Period Open:26.22
Price movement based on the high, low and last over the given period.
27.32 -17.24% decrease
on 10/06/20
-3.61 (-13.77%) decrease
since 09/29/20
3-Month 20.61 +9.70% increase
on 10/21/20
Period Open:35.99
Price movement based on the high, low and last over the given period.
41.69 -45.77% decrease
on 08/05/20
-13.38 (-37.18%) decrease
since 07/29/20
52-Week 17.34 +30.35% increase
on 11/05/19
Period Open:21.00
Price movement based on the high, low and last over the given period.
41.69 -45.77% decrease
on 08/05/20
+1.61 (+7.67%) increase
since 10/29/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies